Reviewer: QIAO Gui-bin, Literature Co-worker: ZHANG Tao. The Application of Geftinib as Adjuvant Therapy for Stage Ⅱ~ⅢA EGFR-Mutant Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 230-232. DOI: 10.12019/j.issn.1671-5144.2018.04.010
|
Citation:
|
Reviewer: QIAO Gui-bin, Literature Co-worker: ZHANG Tao. The Application of Geftinib as Adjuvant Therapy for Stage Ⅱ~ⅢA EGFR-Mutant Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 230-232. DOI: 10.12019/j.issn.1671-5144.2018.04.010
|
Reviewer: QIAO Gui-bin, Literature Co-worker: ZHANG Tao. The Application of Geftinib as Adjuvant Therapy for Stage Ⅱ~ⅢA EGFR-Mutant Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 230-232. DOI: 10.12019/j.issn.1671-5144.2018.04.010
|
Citation:
|
Reviewer: QIAO Gui-bin, Literature Co-worker: ZHANG Tao. The Application of Geftinib as Adjuvant Therapy for Stage Ⅱ~ⅢA EGFR-Mutant Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 230-232. DOI: 10.12019/j.issn.1671-5144.2018.04.010
|
DownLoad: